Form 4 for HROW HARROW, INC.
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-01 · accession 0001493152-24-008930 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-06 | 2024-03-01 | HROW | SAHAREK JOHN P. | CEO of ImprimisRx | M - OptEx | $8.75 | +5,000 | 254.8K | +2% | +$43.8K |
| D | 2024-03-06 | 2024-03-01 | HROW | SAHAREK JOHN P. | CEO of ImprimisRx | M - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-03-01 | M | A | 5,000 | $8.75 | 254,803 | D | — | — | (F1) The stock option was granted on March 3, 2014 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of March 3, 2024. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-03-01 | M | D | 5,000 | $0.00 | 0 | D | $8.75 · — to 2024-03-03 | 5,000 Common Stock | (F1) The stock option was granted on March 3, 2014 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of March 3, 2024. |